Respiratory tract infections are caused by a large number of viral, bacterial, and fungal pathogens, which all produce overlapping symptoms. Because current tests are pathogen driven, they require multiple testings to achieve accurate diagnosis. Even when successful, these test provide limited genetic information.
FUSION GENOMICS is developing a Multiplex Upper Respiratory ONETest™ (MURONTest) based on specifications by Key Opinion Leaders from Canada, EU and the pharmaceutical industry. The test is expected to detect over 25 pathogens with more than 100 subtypes and provide key information on genomic regions of interest for diagnosis, antibiotic resistance, detection of virulent strains and vaccine development.